Question 1

What is the current probability for "FDA decision: Roflumilast (ARQ-151) by Arcutis Biotherapeutics (June 2026)"?

Accepted Answer

Current Kalshi odds for "FDA decision: Roflumilast (ARQ-151) by Arcutis Biotherapeutics (June 2026)": Full Approval 85%, Withdrawn by Sponsor 17%, No Decision 8% (top 3 of 5 outcomes), refreshed continuously.

Question 2

When does this market resolve?

Accepted Answer

This event resolves on 7/8/2026.

Question 3

How is the probability calculated?

Accepted Answer

pdata reads the latest market prices directly from kalshi's public API and normalizes them to a 0-100 probability scale. See https://pdata.world/methodology for details on per-platform conventions.

Question 4

Where can I get this data programmatically?

Accepted Answer

The JSON endpoint is https://api.pdata.world/api/v1/events/kalshi/KXROFLUMILAST-26. An MCP server with 9 tools is available at https://api.pdata.world/mcp. Full agent guide: https://pdata.world/agents.md.

FDA decision: Roflumilast (ARQ-151) by Arcutis Biotherapeutics (June 2026)

similar markets